Wermelskirchen, Germany

Maria Theresia Niewohner, Legal Representative


Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Maria Theresia Niewohner: A Pioneer in Pharmaceutical Innovations

Introduction

Maria Theresia Niewohner is a notable inventor based in Wermelskirchen, Germany. With four patents to her name, she has made significant contributions to the field of pharmaceuticals, particularly focusing on the development of innovative treatments.

Latest Patents

Her latest patents include groundbreaking work on the "Use of 2-alkoxyphenyl-substituted imidazotriazinones." This invention explores the application of known 2-phenyl-substituted imidazotriazinones with specific properties for producing medicaments. The potential treatments target various health conditions, including cardiac insufficiency, psoriasis, diabetes, and even certain types of cancer. Additionally, she has developed novel imidazotriazinones and methods for their production and pharmaceutical use.

Career Highlights

Throughout her career, Maria has worked with renowned companies such as Bayer Pharmaceuticals Corporation. Her work has been influential in advancing pharmaceutical sciences, particularly in the area of compounds that offer unique medicinal benefits.

Collaborations

Maria Theresia Niewohner has collaborated with distinguished colleagues such as Karl-Heinz Schlemmer and Helmut Haning. These partnerships have enabled her to deepen her research and widen the impact of her inventions.

Conclusion

Maria Theresia Niewohner stands out as an innovative inventor whose patents reflect her dedication to improving health outcomes. Her contributions to the pharmaceutical industry not only illustrate her expertise but also highlight the importance of research and collaboration in driving medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…